Lantheus Holdings

lantheus.com

Lantheus is a leading radiopharmaceutical-focused company with over 65 years of experience in developing, manufacturing, and commercializing innovative diagnostic and therapeutic products. Their portfolio includes precision diagnostics for non-oncologic conditions and radiopharmaceutical oncology products that help clinicians Find, Fight and Follow® cancer. Lantheus differentiates itself through its pioneering advancements in medical imaging, novel therapeutics, and AI technologies, positioning itself as a key player in improving patient outcomes. The company has a rich history of transformative mergers and acquisitions, and it continues to forge partnerships that empower precision medicine through the use of biomarkers and digital solutions.